UBR5 interacts with the replication fork and protects DNA replication from DNA polymerase η toxicity.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
02 12 2019
Historique:
accepted: 25 09 2019
revised: 06 09 2019
received: 13 02 2019
pubmed: 6 10 2019
medline: 2 6 2020
entrez: 6 10 2019
Statut: ppublish

Résumé

Accurate DNA replication is critical for the maintenance of genome integrity and cellular survival. Cancer-associated alterations often involve key players of DNA replication and of the DNA damage-signalling cascade. Post-translational modifications play a fundamental role in coordinating replication and repair and central among them is ubiquitylation. We show that the E3 ligase UBR5 interacts with components of the replication fork, including the translesion synthesis (TLS) polymerase polη. Depletion of UBR5 leads to replication problems, such as slower S-phase progression, resulting in the accumulation of single stranded DNA. The effect of UBR5 knockdown is related to a mis-regulation in the pathway that controls the ubiquitylation of histone H2A (UbiH2A) and blocking this modification is sufficient to rescue the cells from replication problems. We show that the presence of polη is the main cause of replication defects and cell death when UBR5 is silenced. Finally, we unveil a novel interaction between polη and H2A suggesting that UbiH2A could be involved in polη recruitment to the chromatin and the regulation of TLS.

Identifiants

pubmed: 31586398
pii: 5581729
doi: 10.1093/nar/gkz824
pmc: PMC6868395
doi:

Substances chimiques

DNA, Single-Stranded 0
Histones 0
UBR5 protein, human EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27
DNA-Directed DNA Polymerase EC 2.7.7.7
POLN protein, human EC 2.7.7.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11268-11283

Subventions

Organisme : Medical Research Council
ID : MR/N021002/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12091-6
pubmed: 25092319
Pathology. 2010 Jan;42(1):93-4
pubmed: 20025491
Cell Cycle. 2012 Feb 15;11(4):715-20
pubmed: 22374670
Genes Cells. 2006 Jul;11(7):731-44
pubmed: 16824193
EMBO J. 2004 Oct 1;23(19):3886-96
pubmed: 15359278
Genes Dev. 2001 Jan 15;15(2):158-72
pubmed: 11157773
Genes Cells. 2008 Apr;13(4):343-54
pubmed: 18363965
Nat Rev Mol Cell Biol. 2012 Feb 23;13(3):141-52
pubmed: 22358330
Genes Dev. 2006 May 15;20(10):1343-52
pubmed: 16702407
Nature. 2015 Nov 19;527(7578):389-93
pubmed: 26503038
Cell. 2007 Nov 30;131(5):901-14
pubmed: 18001825
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Oct 1;68(Pt 10):1158-63
pubmed: 23027739
Mol Biol Cell. 2008 Dec;19(12):5193-202
pubmed: 18799611
Mol Cancer Res. 2015 Dec;13(12):1523-32
pubmed: 26464214
J Biol Chem. 2006 Oct 27;281(43):32081-8
pubmed: 16959771
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nat Commun. 2016 Nov 04;7:13326
pubmed: 27811911
J Biol Chem. 2011 Jul 15;286(28):le13; author reply le14
pubmed: 21757764
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):E20; author reply E21
pubmed: 19240217
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Front Genet. 2016 May 13;7:87
pubmed: 27242895
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5361-6
pubmed: 18385374
Cell. 2012 Sep 14;150(6):1182-95
pubmed: 22980979
Mol Cell. 2005 Sep 16;19(6):805-15
pubmed: 16168375
Cell. 2012 Aug 17;150(4):697-709
pubmed: 22884692
Science. 2007 Dec 7;318(5856):1637-40
pubmed: 18006705
N Engl J Med. 2009 Oct 8;361(15):1475-85
pubmed: 19812404
Chromosome Res. 2013 Mar;21(1):87-100
pubmed: 23463495
J Cell Biol. 2011 Jan 24;192(2):219-27
pubmed: 21242293
Cell Cycle. 2007 Dec 15;6(24):3070-7
pubmed: 18073532
Cell Cycle. 2012 Jul 1;11(13):2538-44
pubmed: 22713238
DNA Repair (Amst). 2007 Jan 4;6(1):121-7
pubmed: 17035102
EMBO J. 2012 Feb 15;31(4):908-18
pubmed: 22157819
EMBO J. 2002 Nov 15;21(22):6246-56
pubmed: 12426396
Cell. 2007 Nov 30;131(5):887-900
pubmed: 18001824
Nat Cell Biol. 2006 Apr;8(4):339-47
pubmed: 16531995
DNA Repair (Amst). 2015 Dec;36:2-7
pubmed: 26507443
Curr Protoc Mol Biol. 2010 Oct;Chapter 14:Unit14.20
pubmed: 20890901
Mol Cell. 2013 Mar 7;49(5):795-807
pubmed: 23416108
J Biol Chem. 2006 Dec 29;281(52):39990-40000
pubmed: 17074762
Cell. 2009 Feb 6;136(3):435-46
pubmed: 19203579
Mol Cell. 2004 May 21;14(4):491-500
pubmed: 15149598
Nucleic Acids Res. 2017 Sep 19;45(16):9441-9454
pubmed: 28934491
Nat Rev Mol Cell Biol. 2013 May;14(5):269-82
pubmed: 23594953
Blood. 2013 Apr 18;121(16):3161-4
pubmed: 23407552
J Cell Biol. 1998 Mar 23;140(6):1285-95
pubmed: 9508763
Mol Cell. 2010 Feb 12;37(3):396-407
pubmed: 20159558
Nat Rev Mol Cell Biol. 2015 Jun;16(6):360-74
pubmed: 25999062
Science. 2005 Dec 16;310(5755):1821-4
pubmed: 16357261
Mol Cell. 2018 Sep 20;71(6):897-910.e8
pubmed: 30122534
Cell. 2009 Feb 6;136(3):420-34
pubmed: 19203578
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16125-30
pubmed: 18845679
J Biol Chem. 2011 Apr 29;286(17):14972-82
pubmed: 21383020
Nucleic Acids Res. 2012 Aug;40(15):7393-403
pubmed: 22638582
Genome Biol. 2006;7(10):R100
pubmed: 17076895

Auteurs

Lina Cipolla (L)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, Pavia, Italy.

Federica Bertoletti (F)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, Pavia, Italy.

Antonio Maffia (A)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, Pavia, Italy.

Chih-Chao Liang (CC)

Department of Biochemistry, University of Oxford, Oxford, UK.

Alan R Lehmann (AR)

Genome Damage and Stability Centre, University of Sussex, Brighton, UK.

Martin A Cohn (MA)

Department of Biochemistry, University of Oxford, Oxford, UK.

Simone Sabbioneda (S)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", CNR, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH